Curaleaf Files Q1 2026 Interim Financials on Form 6-K

Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Curaleaf Holdings ( (TSE:CURA) ) has shared an announcement. Curaleaf Holdings, Inc. filed a Form 6-K with the U.S. Securities and Exchange Commission in May 2026, reporting unaudited condensed interim consolidated financial statements as of March 31, 2026 and December 31, 2025. The filing also covers results for the three months ended March 31, 2026 and 2025, together with management’s discussion and analysis, indicating routine quarterly disclosure for investors. The submission, signed on May 5, 2026 by Chief Legal Officer Peter Clateman, incorporates the interim financial package into Curaleaf’s existing Form F-10 registration statement. By attaching CEO and CFO certifications and a concurrent press release, the company reinforces compliance and transparency as it maintains access to U.S. public markets and provides updated financial information to shareholders and other stakeholders. The most recent analyst rating on (TSE:CURA) stock is a Buy with a C$5.50 price target. To see the full list of analyst forecasts on Curaleaf Holdings stock, see the TSE:CURA Stock Forecast page. Spark’s Take on CURA Stock According to Spark, TipRanks’ AI Analyst, CURA is a Neutral. The score is supported by improving cash-flow resilience and constructive technical momentum, plus a generally positive earnings-call backdrop (sequential growth guidance, profitability swing, refinancing progress). These are tempered by still-weak underlying profitability in the financial statements, margin compression, and a valuation profile that remains constrained by loss-making history and no dividend. To see Spark’s full report on CURA stock, click here. More about Curaleaf Holdings Curaleaf Holdings, Inc. is a cannabis company based in Vancouver, Canada, operating as a foreign private issuer in U.S. capital markets. The group cultivates, processes and sells cannabis products across regulated markets, and its securities are registered with the U.S. Securities and Exchange Commission under the multijurisdictional disclosure system. Average Trading Volume: 766,788 Technical Sentiment Signal: Buy Current Market Cap: C$3.45B Find detailed analytics on CURA stock on TipRanks’ Stock Analysis page.